Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses.

Cao W, Mishina M, Amoah S, Mboko WP, Bohannon C, McCoy J, Mittal SK, Gangappa S, Sambhara S.

Drug Deliv. 2018 Nov;25(1):773-779. doi: 10.1080/10717544.2018.1450909.

2.

Correction for Mounce et al., "A Conserved Gammaherpesvirus Protein Kinase Targets Histone Deacetylases 1 and 2 To Facilitate Viral Replication in Primary Macrophages".

Mounce BC, Mboko WP, Bigley TM, Terhune SS, Tarakanova VL.

J Virol. 2017 Dec 14;92(1). pii: e01601-17. doi: 10.1128/JVI.01601-17. Print 2018 Jan 1. No abstract available.

3.

B Cell-Specific Expression of Ataxia-Telangiectasia Mutated Protein Kinase Promotes Chronic Gammaherpesvirus Infection.

Darrah EJ, Kulinski JM, Mboko WP, Xin G, Malherbe LP, Gauld SB, Cui W, Tarakanova VL.

J Virol. 2017 Sep 12;91(19). pii: e01103-17. doi: 10.1128/JVI.01103-17. Print 2017 Oct 1.

4.

Interferon Regulatory Factor 1 and Type I Interferon Cooperate To Control Acute Gammaherpesvirus Infection.

Mboko WP, Rekow MM, Ledwith MP, Lange PT, Schmitz KE, Anderson S, Tarakanova VL.

J Virol. 2016 Dec 16;91(1). pii: e01444-16. doi: 10.1128/JVI.01444-16. Print 2017 Jan 1.

5.

Gammaherpesvirus targets peritoneal B-1 B cells for long-term latency.

Rekow MM, Darrah EJ, Mboko WP, Lange PT, Tarakanova VL.

Virology. 2016 May;492:140-4. doi: 10.1016/j.virol.2016.02.022. Epub 2016 Mar 21.

6.

Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection.

Lange PT, Darrah EJ, Vonderhaar EP, Mboko WP, Rekow MM, Patel SB, Sidjanin DJ, Tarakanova VL.

J Virol. 2016 Jan 6;90(7):3342-54. doi: 10.1128/JVI.02277-15.

7.

Tumor Suppressor Interferon-Regulatory Factor 1 Counteracts the Germinal Center Reaction Driven by a Cancer-Associated Gammaherpesvirus.

Mboko WP, Olteanu H, Ray A, Xin G, Darrah EJ, Kumar SN, Kulinski JM, Cui W, Dittel BN, Gauld SB, Tarakanova VL.

J Virol. 2015 Dec 30;90(6):2818-29. doi: 10.1128/JVI.02774-15.

8.

ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection.

Kulinski JM, Darrah EJ, Broniowska KA, Mboko WP, Mounce BC, Malherbe LP, Corbett JA, Gauld SB, Tarakanova VL.

Virology. 2015 Sep;483:264-74. doi: 10.1016/j.virol.2015.04.026. Epub 2015 May 21.

9.

Interferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells.

Mboko WP, Mounce BC, Emmer J, Darrah E, Patel SB, Tarakanova VL.

J Virol. 2014 Jun;88(12):6993-7004. doi: 10.1128/JVI.00638-14. Epub 2014 Apr 9.

10.

Primary macrophages rely on histone deacetylase 1 and 2 expression to induce type I interferon in response to gammaherpesvirus infection.

Mounce BC, Mboko WP, Kanack AJ, Tarakanova VL.

J Virol. 2014 Feb;88(4):2268-78. doi: 10.1128/JVI.03278-13. Epub 2013 Dec 11.

11.

Mouse gammaherpesvirus-68 infection acts as a rheostat to set the level of type I interferon signaling in primary macrophages.

Wood BM, Mboko WP, Mounce BC, Tarakanova VL.

Virology. 2013 Aug 15;443(1):123-33. doi: 10.1016/j.virol.2013.04.036. Epub 2013 May 23.

12.

A conserved gammaherpesvirus protein kinase targets histone deacetylases 1 and 2 to facilitate viral replication in primary macrophages.

Mounce BC, Mboko WP, Bigley TM, Terhune SS, Tarakanova VL.

J Virol. 2013 Jul;87(13):7314-25. doi: 10.1128/JVI.02713-12. Epub 2013 Apr 24. Erratum in: J Virol. 2017 Dec 14;92 (1):.

13.

Coordinate regulation of DNA damage and type I interferon responses imposes an antiviral state that attenuates mouse gammaherpesvirus type 68 replication in primary macrophages.

Mboko WP, Mounce BC, Wood BM, Kulinski JM, Corbett JA, Tarakanova VL.

J Virol. 2012 Jun;86(12):6899-912. doi: 10.1128/JVI.07119-11. Epub 2012 Apr 11.

Supplemental Content

Loading ...
Support Center